연구성과로 돌아가기
2022 연구자 정보 (547 / 1074)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Bae, Eunjin (Bae, E) |
Tokyo Med Univ, Dept Mol Pathol, Tokyo, Japan Kyungpook Natl Univ Hosp, Biomed Res Inst, Daegu, South Korea Konkuk Univ, Lab Anim Med, Coll Vet Med, Seoul, South Korea Gyeongsang Natl Univ, Grad Sch Med, Chang Won, Gyeongsangnam D, South Korea Gyeongsang Natl Univ, Dept Internal Med, Div Nephrol, Coll Med, Jinju, South Korea Gyeongsang Natl Univ, Dept Internal Med, Div Nephrol, Changwon Hosp, Chang Won, South Korea |
|
|
[JCR상위 25.5] Intense ALK5 inhibition facilitates progression and metastasis of mouse melanoma [JCR상위 5.1] Prediction Model for 6-Month Mortality in Incident Older Hemodialysis Patients: Data From the Korean Society of Geriatric Nephrology [JCR상위 23.0] Association between physical activity and risk of renal function decline and mortality in community-dwelling older adults: a nationwide population-based cohort study [JCR상위 36.9] Effect of shared decision-making education on physicians' perceptions and practices of end-of-life care in Korea |
SCIE SCIE;SSCI |
5.1 |
ONCOLOGY UROLOGY & NEPHROLOGY GERIATRICS & GERONTOLOGY;GERONTOLOGY |
amorfati@catholic.ac.kr; shine@med.donggukac.kr;shine@med.dongguk.ac.kr; |
||
|
Eunjin, Bae (Eunjin, B) |
제1저자 |
Tokyo Med Univ, Dept Mol Pathol, Tokyo, Japan Kyungpook Natl Univ Hosp, Biomed Res Inst, Daegu, South Korea Konkuk Univ, Coll Vet Med, Lab Anim Med, Seoul, South Korea |
|
|
[JCR상위 25.5] Linker-phosphorylated SMAD2 induces resistance to tyrosine kinase inhibition in EGFR-mutated lung adenocarcinoma | SCIE | 25.5 | ONCOLOGY | ||
|
Han, Jinsoo (Han, J) |
Konkuk Univ, Lab Anim Med, Coll Vet Med, Seoul, South Korea Konkuk Univ, Coll Vet Med, Lab Anim Med, Seoul, South Korea |
|
|
[JCR상위 25.5] Intense ALK5 inhibition facilitates progression and metastasis of mouse melanoma [JCR상위 25.5] Linker-phosphorylated SMAD2 induces resistance to tyrosine kinase inhibition in EGFR-mutated lung adenocarcinoma |
SCIE | 25.5 | ONCOLOGY | |||
|
Ikeda, Norihiko (Ikeda, N) |
Tokyo Med Univ, Dept Surg, Tokyo, Japan |
|
|
[JCR상위 25.5] Linker-phosphorylated SMAD2 induces resistance to tyrosine kinase inhibition in EGFR-mutated lung adenocarcinoma | SCIE | 25.5 | ONCOLOGY | |||
|
Jeonghwan, Yoon (Jeonghwan, Y) |
제1저자 |
Tokyo Med Univ, Dept Mol Pathol, Tokyo, Japan Kyungpook Natl Univ Hosp, Biomed Res Inst, Daegu, South Korea Konkuk Univ, Lab Anim Med, Coll Vet Med, Seoul, South Korea |
|
|
[JCR상위 25.5] Intense ALK5 inhibition facilitates progression and metastasis of mouse melanoma | SCIE | 25.5 | ONCOLOGY | ||
|
Ju, Jihyun (Ju, J) |
Catholic Univ, St Mary Hosp, Dept Rheumatol, Seoul, South Korea Catholic Univ, Dept Rheumatol, St Mary Hosp, Seoul, South Korea |
|
|
[JCR상위 25.5] Intense ALK5 inhibition facilitates progression and metastasis of mouse melanoma [JCR상위 25.5] Linker-phosphorylated SMAD2 induces resistance to tyrosine kinase inhibition in EGFR-mutated lung adenocarcinoma |
SCIE | 25.5 | ONCOLOGY | |||
|
Kato, Mitsuyasu (Kato, M) |
Univ Tsukuba, Dept Expt Pathol, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan Univ Tsukuba, Fac Med, Tsukuba, Ibaraki, Japan |
|
|
[JCR상위 25.5] Linker-phosphorylated SMAD2 induces resistance to tyrosine kinase inhibition in EGFR-mutated lung adenocarcinoma | SCIE | 25.5 | ONCOLOGY | |||
|
Kuroda, Masahiko (Kuroda, M) |
Tokyo Med Univ, Dept Mol Pathol, Tokyo, Japan |
|
|
[JCR상위 25.5] Intense ALK5 inhibition facilitates progression and metastasis of mouse melanoma [JCR상위 25.5] Linker-phosphorylated SMAD2 induces resistance to tyrosine kinase inhibition in EGFR-mutated lung adenocarcinoma |
SCIE | 25.5 | ONCOLOGY | |||
|
Lee, Inkyu (Lee, I) |
Kyungpook Natl Univ Hosp, Biomed Res Inst, Daegu, South Korea |
|
|
[JCR상위 25.5] Intense ALK5 inhibition facilitates progression and metastasis of mouse melanoma [JCR상위 25.5] Linker-phosphorylated SMAD2 induces resistance to tyrosine kinase inhibition in EGFR-mutated lung adenocarcinoma |
SCIE | 25.5 | ONCOLOGY | |||
|
Makino, Yojiro (Makino, Y) |
Tokyo Med Univ, Dept Surg, Tokyo, Japan |
|
|
[JCR상위 25.5] Linker-phosphorylated SMAD2 induces resistance to tyrosine kinase inhibition in EGFR-mutated lung adenocarcinoma | SCIE | 25.5 | ONCOLOGY | |||
|
Mamura, Mizuko (Mamura, M) |
Tokyo Med Univ, Dept Mol Pathol, Tokyo, Japan Kyungpook Natl Univ Hosp, Biomed Res Inst, Daegu, South Korea |
|
|
[JCR상위 25.5] Intense ALK5 inhibition facilitates progression and metastasis of mouse melanoma [JCR상위 25.5] Linker-phosphorylated SMAD2 induces resistance to tyrosine kinase inhibition in EGFR-mutated lung adenocarcinoma |
SCIE | 25.5 | ONCOLOGY | |||
|
Miyazawa, Keiji (Miyazawa, K) |
Univ Yamanashi, Dept Biochem, Kofu, Yamanashi, Japan |
I-9713-2014 MIYAZAWA, KEIJI |
|
[JCR상위 25.5] Linker-phosphorylated SMAD2 induces resistance to tyrosine kinase inhibition in EGFR-mutated lung adenocarcinoma | SCIE | 25.5 | ONCOLOGY | |||
|
Nagao, Toshitaka (Nagao, T) |
Tokyo Med Univ, Dept Anat Pathol, Tokyo, Japan |
|
|
[JCR상위 25.5] Linker-phosphorylated SMAD2 induces resistance to tyrosine kinase inhibition in EGFR-mutated lung adenocarcinoma | SCIE | 25.5 | ONCOLOGY | |||
|
Ohira, Tatsuo (Ohira, T) |
Tokyo Med Univ, Dept Surg, Tokyo, Japan |
|
|
[JCR상위 25.5] Linker-phosphorylated SMAD2 induces resistance to tyrosine kinase inhibition in EGFR-mutated lung adenocarcinoma | SCIE | 25.5 | ONCOLOGY | |||
|
Sukeda, Aoi (Sukeda, A) |
Tokyo Med Univ, Dept Anat Pathol, Tokyo, Japan |
|
|
[JCR상위 25.5] Linker-phosphorylated SMAD2 induces resistance to tyrosine kinase inhibition in EGFR-mutated lung adenocarcinoma | SCIE | 25.5 | ONCOLOGY |
페이지 이동: